Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haoxi Health Technology (HAO) Inventory (2023 - 2025)

Haoxi Health Technology's Inventory history spans 3 years, with the latest figure at $7.4 million for Q4 2025.

  • Quarterly Inventory rose 1451.99% to $7.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.4 million through Dec 2025, up 1451.99% year-over-year, with the annual reading at $5.7 million for FY2025, 10.15% up from the prior year.
  • Inventory came in at $7.4 million for Q4 2025, up from $5.7 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $7.4 million in Q4 2025 to a low of -$1.0 million in Q4 2023.
  • The 3-year median for Inventory is $3.8 million (2023), against an average of $3.2 million.
  • The largest YoY upside for Inventory was 1451.99% in 2025 against a maximum downside of 10.15% in 2025.
  • Haoxi Health Technology's Inventory stood at -$1.0 million in 2023, then skyrocketed by 45.5% to -$545599.0 in 2024, then soared by 1451.99% to $7.4 million in 2025.
  • Per Business Quant, the three most recent readings for HAO's Inventory are $7.4 million (Q4 2025), $5.7 million (Q2 2025), and -$545599.0 (Q4 2024).